•
Higher discontinuation for: younger pts;
comorbidity; Prescription via GP.
•
persistence with all endocrine treatments in
women with hormonereceptor-positive BC is
low.
Amir E, et al. JNCI 2011;103:1299-1309
Less local treatment: where is the limit?
Side effects